Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Oktober 2021

Biotek-snakken — Oktober 2021

Planlagt Fastgjort Låst Flyttet Biotek-snakken
168 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • F Offline
    F Offline
    Fandel
    wrote on sidst redigeret af
    #68

    Godmorgen...

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #69

      Chr. Hansen- Studie; BB-12® til børn med colic https://www.proinvestor.com/index.php?p=debat_1&postid=97917

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #70

        Pfizer og Moderna venter en fordobling af vaccinesalg i 2022
        https://www.proinvestor.com/investornyt/719211/pfizer-og-moderna-venter-en-fordobling-af-vaccinesalg-i-2022

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #71

          2 Biotech Stocks Set to Go Supernova Soon https://www.proinvestor.com/investornyt/719296/2-biotech-stocks-set-to-go-supernova-soon

          1 Reply Last reply
          0
          • F Offline
            F Offline
            Fandel
            wrote on sidst redigeret af
            #72

            Er med i Anavex, så følger den tæt.

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #73

              Har begge 🙂

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #74

                Is Moderna a Good Healthcare Stock to Buy Now? https://www.proinvestor.com/investornyt/719337/is-moderna-a-good-healthcare-stock-to-buy-now

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #75

                  These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday
                  https://www.proinvestor.com/investornyt/719336/these-2-nasdaq-biotechs-are-making-huge-premarket-moves-monday

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #76

                    Radius Reports Positive Phase 3 Results For TYMLOS Subcutaneous Injection In Males With Osteoporosis https://www.proinvestor.com/investornyt/719346/radius-reports-positive-phase-3-results-for-tymlos-subcutaneous-injection-in-males-with-osteoporosis

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      lahn1
                      wrote on sidst redigeret af
                      #77

                      ZYME: det er ved at blive the hårdt at være aktionær. Tror de har gang i deres ATM :-(, Nå men den kommer jo nok op igen når vi har gode data

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        DevOp
                        wrote on sidst redigeret af
                        #78

                        Entasis: så kom der positive ph3 data på SUL-DUR, endpoints met. Conf call Oct 19 8:00am ET https://www.globenewswire.com/news-release/2021/10/18/2316018/0/en/Entasis-Therapeutics-announces-positive-topline-results-for-sulbactam-durlobactam-SUL-DUR-from-Phase-3-ATTACK-trial.html

                        1 Reply Last reply
                        0
                        • L Offline
                          L Offline
                          lahn1
                          wrote on sidst redigeret af
                          #79

                          Er helt klar til optur, men fuck solgte de ikke lige 20M aktier til INVA for $2,5 i sidste uge? De må sgu da være kriminelt.

                          1 Reply Last reply
                          0
                          • R Offline
                            R Offline
                            radar24
                            wrote on sidst redigeret af
                            #80

                            Entasis er oppe med ca. 25% i eftermarkedet !! det bliver spændende i morgen.

                            1 Reply Last reply
                            0
                            • F Offline
                              F Offline
                              Fandel
                              wrote on sidst redigeret af
                              #81

                              Godmorgen...

                              1 Reply Last reply
                              0
                              • R Offline
                                R Offline
                                Rasbom
                                wrote on sidst redigeret af
                                #82

                                Photocure:Full publication from U.S. registry now available, highlighting the Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor.https://photocure.com/news/full-publication-from-u.s.-registry-now-available-highlighting-the-role-of-blue-light-cystoscopy-in-detecting-invasive-bladder-tumor/

                                1 Reply Last reply
                                0
                                • R Offline
                                  R Offline
                                  Rasbom
                                  wrote on sidst redigeret af
                                  #83

                                  Det er jo ikke under hold i virkeligheden at Photocures CEO mener at de kan blive Standard of Care

                                  1 Reply Last reply
                                  0
                                  • R Offline
                                    R Offline
                                    Rasbom
                                    wrote on sidst redigeret af
                                    #84

                                    Nordic Nanovector:Nordic Nanovector ASA (OSE: NANOV) is pleased to announce that it has entered into a research collaboration with the University of Pennsylvania ("Penn") to generate a CD37-targeting CAR-T cell approach as a potential treatment for patients with B-cell malignancieshttps://www.nordicnanovector.com/investors-and-media/press-releases?page=/press/perma/1955736

                                    1 Reply Last reply
                                    0
                                    • R Offline
                                      R Offline
                                      Rasbom
                                      wrote on sidst redigeret af
                                      #85

                                      Interessant medling med perspektiv. Vi nærmere os også med hastige skridt afslutningen på Nordic Nanovectors registreringsstudie for Betalutin i NHL, 3. line behandling.

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #86

                                        Atea Pharmaceuticals skuffer med middel mod covid-19 og falder 70 pct.
                                        https://www.proinvestor.com/investornyt/719889/atea-pharmaceuticals-skuffer-med-middel-mod-covid-19-og-falder-70-pct

                                        1 Reply Last reply
                                        0
                                        • F Offline
                                          F Offline
                                          Fandel
                                          wrote on sidst redigeret af
                                          #87

                                          Av for den....

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper